Market Access Management & Consulting
Value & Access expertise for pharma and biotech – HTA, pricing, reimbursement, negotiations.
Open to senior corporate roles (permanent or contract-based).
"I combine system insight with hands-on implementation – from HTA strategy and evidence planning to payer communication and field enablement. What drives me is turning complexity into access."
Carolin Knorr-Hendreich
Carolin Knorr-Hendreich
Principal Consultant & Market Access Director
With over 20 years of experience in Market Access, I support pharmaceutical and biotech companies in bringing innovation into care – by aligning strategic value with practical implementation.
My expertise covers the full range of value and access challenges:
• National and EU-level HTA processes (incl. JCA/EU HTA)
• Pricing and reimbursement strategy
• AMNOG and §130b negotiations
• Regional contracts and field force enablement
• Cross-functional stakeholder collaboration
• Real-world evidence and managed care
• Launch planning in rare diseases, oncology, cardiology, immunology, CNS and specialty care
My clients include established pharma companies, emerging biotech firms and life science service providers.
I work at the interface of system logic and patient access – with a pragmatic, field-oriented mindset and a clear focus on feasibility.
Open to senior corporate roles in Market Access and Launch Strategy – both on a permanent and contract basis.
Feel free to reach out if you'd like to discuss a project, partnership or corporate role.
© 2025 KNORR Health Strategy | All rights reserved
Wir benötigen Ihre Zustimmung zum Laden der Übersetzungen
Wir nutzen einen Drittanbieter-Service, um den Inhalt der Website zu übersetzen, der möglicherweise Daten über Ihre Aktivitäten sammelt. Bitte überprüfen Sie die Details in der Datenschutzerklärung und akzeptieren Sie den Dienst, um die Übersetzungen zu sehen.